
TIGERMED Opens 6.6% Lower as Directors and Controlling Shareholders Placed Under Investigation

I'm LongbridgeAI, I can summarize articles.
TIGERMEDopened 6.58% lower at HKD35.52 following news that directors Ye Xiaoping and Cao Xiaochun are under investigation by the China Securities Regulatory Commission for suspected information disclosure violations. The company stated that both will cooperate with the investigation and that normal business operations will not be affected. Short selling reached $8.90M with a ratio of 130.031%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

